Patents by Inventor Nolan Robert Campbell

Nolan Robert Campbell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTENDED INTERVAL DOSING OF NATALIZUMAB
    Publication number: 20210188982
    Abstract: Provided herein, in some embodiments, are methods for reducing the risk of developing progressive multifocal leukemia in patients undergoing natalizumab therapy by switching to an extended interval dosing (EID) schedule.
    Type: Application
    Filed: October 25, 2018
    Publication date: June 24, 2021
    Inventors: Nolan Robert Campbell, Ih Chang, Bharath Kumar Kandadi Muralidharan, Ivan Alexandrov Nestorov